The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Apoproteins B and A-I and coronary artery disease in humans.
Open accessAbstract
T his review initially will consider the association between premature coronary artery disease and abnormal lipoprotein cholesterol levels, but then focus on recent evidence linking the apoproteins of lipoproteins to atherosclerosis.This evidence suggests that although cholesterol is the major component common to the plasma and the arterial wall, plasma apoproteins may serve as a better marker of risk for atherosclerosis. HyperlipidemiaThe association between serum cholesterol levels and atherosclerosis in humans was suggested when Thannhauser and Muller in 1938 each demonstrated familial aggregation of individuals with tendon xanthomata, hypercholesterolemia, and coronary artery disease (CAD). 1 The association was generalized by studies such as those in Framingham which demonstrated that the risk for coronary artery disease rose over the entire range of serum cholesterol.This relation was seen predominantly in those persons 30 to 49 years of age at entry into the study 2 and most markedly in those 30 to 39 years old.34 Different lipoproteins affect risk differently.Among subjects 49 years and older, low density lipoprotein (LDL) cholesterol was associated with moderate CAD risk, 5 as had been suggested earlier by Gofman et al.; 6 however, in these older individuals, the high density lipo-
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
The Role of Lipids and Lipoproteins in Atherosclerosis
Gofman, J. W., Lindgren, F., Elliott, H., Mantz, W., Hewitt, J., Strisower, B., Herring, V., & Lyon, T. P. (1950) · Science · doi:10.1126/science.111.2877.166 · Cited by 918
Hulley, S. B., Rosenman, R. H., Bawol, R. D., & Brand, R. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006193022503 · Cited by 702 · cited 1×
“And finally, elevated triglyceride levels have been linked with CAD(8)"(11) but may not be independent of the effect of other lipoproteins or of obesity.(12) In spite of the fact that CAD risk varies over the entire range of plasma concentrations of LDL cholesterol and HDL cholesterol, clinically only those with level…”
BackgroundLipoprotein Lp(a) and the risk for myocardial infarction
Kostner, G. M., Avogaro, P., Cazzolato, G., Marth, E., Bittolo-Bon, G., & Qunici, G. B. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90103-9 · Cited by 687
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bittolo Bon, G., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523
Apolipoprotein E polymorphism and coronary artery disease.
Menzel, H. J., Kladetzky, R. G., & Assmann, G. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.4.310 · Cited by 344
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
Brunzell, J. D., Albers, J. J., Chait, A., Grundy, S. M., Groszek, E., & McDonald, G. B. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38008-1 · Cited by 305
Self-citationMyocardial infarction in the familial forms of hypertriglyceridemia
Brunzell, J. D., Schrott, H. G., Motulsky, A. G., & Bierman, E. L. (1976) · Metabolism · doi:10.1016/0026-0495(76)90089-5 · Cited by 303
Self-citationKissebah, A. H., Alfarsi, S., & Adams, P. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90064-0 · Cited by 295
Cited by
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Familial lipoprotein disorders in patients with premature coronary artery disease.
Genest, J. J., Martin-Munley, S. S., McNamara, J. R., Ordovas, J. M., Jenner, J., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 596
Low density lipoprotein particle size and coronary artery disease.
Campos, H., Genest, J. J., Blijlevens, E., McNamara, J. R., Jenner, J. L., Ordovas, J. M., Wilson, P. W., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.2.187 · Cited by 509
Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476
Metadata
- Authors
- Brunzell, J. D., Sniderman, A. D., Albers, J. J., & Kwiterovich, P. O.
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1984-03
- Volume
- 4
- Issue
- 2
- Pages
- 79-83
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2314171646
- Cited by
- 279
- References
- 27
- FWCI
- 27.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Apoproteins B and A-I and coronary artery disease in humans. https://app.cochat.ai/papers/10.1161/01.atv.4.2.79
- The paper
- Brunzell, J. D., Sniderman, A. D., Albers, J. J., & Kwiterovich, P. O. (1984). Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis: An Official Journal of the American Heart Association, Inc. https://doi.org/10.1161/01.atv.4.2.79
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.